© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 10, 854-868,
May 19, 1999
© 1999 Oxford University Press
Trichloroethylene Exposure and Specific Somatic Mutations in Patients With Renal Cell Carcinoma
Affiliations of authors: H. Brauch, T. Wöhl, Research Laboratory of the Women's Hospital Eppendorf, University of Hamburg, Germany; G. Weirich, M. A. Hornauer, Institute of Pathology, Technical University Munich, Germany; S. Störkel, Institute of Pathology, University of Witten-Herdecke, Wuppertal-Barmen, Germany; T. Brüning, Institute of Occupational Physiology, University of Dortmund, Germany.
Correspondence to present address: Hiltrud Brauch, Ph.D., Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Auerbachstrasse 112, 70376 Stuttgart, Germany (e-mail: hiltrud.brauch{at}ikp-stuttgart.de).
Present addresses: G. Weirich, Laboratory of Immunobiology, National Cancer Institute-Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, MD; T. Wöhl, Wilex Biotechnology GmbH, Munich, Germany.
BACKGROUND: The development of renal cell carcinoma (RCC) has been associated with both genetic and environmental factors—with mutations in the von Hippel-Lindau (VHL) tumor suppressor gene for clear-cell RCC specifically and with long-term exposure to high doses of trichloroethylene (TRI), an industrially important solvent, for RCC generally. We investigated whether TRI exposure produces RCC through a specific mutational effect on the VHL gene by analyzing VHL sequences in the RCCs of patients exposed to high, cumulative doses of TRI. METHODS: The level of exposure for each of 44 patients with RCC who had known industrial exposure to TRI was classified according to the duration, frequency, and mode of exposure. Samples of normal and cancerous tissues were microdissected from paraffin-embedded tissue. DNA was isolated from these samples, and somatic VHL mutations were identified by polymerase chain reaction analysis, single-strand conformation polymorphism analysis, DNA sequencing, and restriction enzyme digestion. Control samples included RCC DNA from 107 patients without known TRI exposure and lymphocyte DNA from 97 healthy subjects. RESULTS: RCCs of TRI-exposed patients showed somatic VHL mutations in 33 (75%) of 44 cases. The mutations were frequently multiple and accompanied by loss of heterozygosity, and there was an association between the number of mutations and the severity of TRI exposure. We observed a specific mutational hot spot at VHL nucleotide 454 in the RCCs of 13 (39%) of the patients, and this mutation was present in adjacent non-neoplastic kidney parenchyma in four of these patients. The nucleotide 454 mutation was neither detected in any of the RCCs from patients without TRI exposure nor in any of the healthy subjects. CONCLUSION: Our results suggest that RCC in patients with high, cumulative TRI exposure is associated with a unique mutation pattern in the VHL gene.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Knauth, E. Cartwright, S. Freund, M. Bycroft, and A. Buchberger VHL Mutations Linked to Type 2C von Hippel-Lindau Disease Cause Extensive Structural Perturbations in pVHL J. Biol. Chem., April 17, 2009; 284(16): 10514 - 10522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Schouten, B. A.C. van Dijk, E. Oosterwijk, M. van Engeland, C. A. Hulsbergen-van de Kaa, L. A.L.M. Kiemeney, R. A. Goldbohm, A. Kester, S. de Vogel, J. A. Schalken, et al. Alcohol Consumption and Mutations or Promoter Hypermethylation of the von Hippel-Lindau Gene in Renal Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3543 - 3550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Jianjun Liu, H. Huang, X. Xing, R. Xi, Z. Zhuang, J. Yuan, F. Yang, and J. Zhao Comparative proteomic analysis on human L-02 liver cells treated with varying concentrations of trichloroethylene Toxicology and Industrial Health, March 1, 2007; 23(2): 91 - 101. [Abstract] [PDF]
|
|
|
|
 |
|
 R. E. Banks, P. Tirukonda, C. Taylor, N. Hornigold, D. Astuti, D. Cohen, E. R. Maher, A. J. Stanley, P. Harnden, A. Joyce, et al. Genetic and Epigenetic Analysis of von Hippel-Lindau (VHL) Gene Alterations and Relationship with Clinical Variables in Sporadic Renal Cancer Cancer Res., February 15, 2006; 66(4): 2000 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Miller, A. Kentsis, R. Osman, and Z.-Q. Pan Inactivation of VHL by Tumorigenic Mutations That Disrupt Dynamic Coupling of the pVHL{middle dot}Hypoxia-inducible Transcription Factor-1{alpha} Complex J. Biol. Chem., March 4, 2005; 280(9): 7985 - 7996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Percy, M. F. McMullin, S. N. Jowitt, M. Potter, M. Treacy, W. H. Watson, and T. R. J. Lappin Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry Blood, August 1, 2003; 102(3): 1097 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ruden Scrutinizing Three Trichloroethylene Carcinogenicity Classifications in the European Union--Implications for the Risk Assessment Process International Journal of Toxicology, November 1, 2002; 21(6): 441 - 450. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Weirich, B. Klein, T. Wohl, D. Engelhardt, and H. Brauch VHL2C Phenotype in a German von Hippel-Lindau Family with Concurrent VHL Germline Mutations P81S and L188V J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5241 - 5246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Siegsmund, U. Brinkmann, E. Schaffeler, G. Weirich, M. Schwab, M. Eichelbaum, P. Fritz, O. Burk, J. Decker, P. Alken, et al. Association of the P-Glycoprotein Transporter MDR1C3435T Polymorphism with the Susceptibility to Renal Epithelial Tumors J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1847 - 1854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hemminki, Y. Jiang, X. Ma, K. Yang, L. Egevad, and P. Lindblad Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients: relation to dietary and other factors Carcinogenesis, May 1, 2002; 23(5): 809 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yang and W. G. Kaelin Jr. Molecular Pathogenesis of the Von Hippel-Lindau Hereditary Cancer Syndrome: Implications for Oxygen Sensing Cell Growth Differ., September 1, 2001; 12(9): 447 - 455. [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Lash and J. C. Parker Hepatic and Renal Toxicities Associated with Perchloroethylene Pharmacol. Rev., May 11, 2001; (2001) 2. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Ojajarvi, T. Partanen, A. Ahlbom, P. Boffetta, T. Hakulinen, N. Jourenkova, T. Kauppinen, M. Kogevinas, H. Vainio, E. Weiderpass, et al. Risk of Pancreatic Cancer in Workers Exposed to Chlorinated Hydrocarbon Solvents and Related Compounds: A Meta-Analysis Am. J. Epidemiol., May 1, 2001; 153(9): 841 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Brauch, G. Weirich, J. Brieger, D. Glavac, H. Rödl, M. Eichinger, M. Feurer, E. Weidt, C. Puranakanitstha, C. Neuhaus, et al. VHL Alterations in Human Clear Cell Renal Cell Carcinoma: Association with Advanced Tumor Stage and a Novel Hot Spot Mutation Cancer Res., April 1, 2000; 60(7): 1942 - 1948. [Abstract] [Full Text]
|
|
|
|
|
|
L. H. Lash and J. C. Parker Hepatic and Renal Toxicities Associated with Perchloroethylene Pharmacol. Rev., June 1, 2001; 53(2): 177 - 208. [Abstract] [Full Text] [PDF]
|
|